{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T08:29:45Z","timestamp":1773304185231,"version":"3.50.1"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T00:00:00Z","timestamp":1661126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T00:00:00Z","timestamp":1661126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100014584","name":"Universit\u00e4tsmedizin der Johannes Gutenberg-Universit\u00e4t Mainz","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014584","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Antagonism of the angiotensin II type 1 receptor (AT1) improves neurological function and reduces brain damage after experimental traumatic brain injury (TBI), which may be partly a result of enhanced indirect angiotensin II type 2 receptor (AT2) stimulation. AT2 stimulation was demonstrated to be neuroprotective via anti-inflammatory, vasodilatory, and neuroregenerative mechanisms in experimental cerebral pathology models. We recently demonstrated an upregulation of AT2 after TBI suggesting a protective mechanism. The present study investigated the effect of post-traumatic (5\u00a0days after TBI) AT2 activation via high and low doses of a selective AT2 agonist, compound 21 (C21), compared to vehicle-treated controls. No differences in the extent of the TBI-induced lesions were found between both doses of C21 and the controls. We then tested AT2-knockdown animals for secondary brain damage after experimental TBI. Lesion volume and neurological outcomes in AT2-deficient mice were similar to those in wild-type control mice at both 24\u00a0h and 5\u00a0days post-trauma. Thus, in contrast to AT1 antagonism, AT2 modulation does not influence the initial pathophysiological mechanisms of TBI in the first 5\u00a0days after the insult, indicating that AT2 plays only a minor role in the early phase following trauma-induced brain damage.\n<\/jats:p>","DOI":"10.1038\/s41598-022-18338-x","type":"journal-article","created":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T12:08:44Z","timestamp":1661170124000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["AT2 activation does not influence brain damage in the early phase after experimental traumatic brain injury in male mice"],"prefix":"10.1038","volume":"12","author":[{"given":"Ralph","family":"Timaru-Kast","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Garcia Bardon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Luh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shila P.","family":"Coronel-Castello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phuriphong","family":"Songarj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva-Verena","family":"Griemert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias J.","family":"Kr\u00e4mer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Sebastiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrike Muscha","family":"Steckelings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serge C.","family":"Thal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,22]]},"reference":[{"key":"18338_CR1","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/00001199-200609000-00001","volume":"21","author":"JA Langlois","year":"2006","unstructured":"Langlois, J. A., Rutland-Brown, W. & Wald, M. M. The epidemiology and impact of traumatic brain injury: A brief overview. J. Head Trauma Rehabil. 21, 375\u2013378 (2006).","journal-title":"J. Head Trauma Rehabil."},{"key":"18338_CR2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/00024382-200116030-00001","volume":"16","author":"MC Morganti-Kossmann","year":"2001","unstructured":"Morganti-Kossmann, M. C., Rancan, M., Otto, V. I., Stahel, P. F. & Kossmann, T. Role of cerebral inflammation after traumatic brain injury: A revisited concept. Shock 16, 165\u2013177 (2001).","journal-title":"Shock"},{"key":"18338_CR3","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s10571-005-4011-5","volume":"25","author":"JM Saavedra","year":"2005","unstructured":"Saavedra, J. M. Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities. Cell Mol. Neurobiol. 25, 485\u2013512 (2005).","journal-title":"Cell Mol. Neurobiol."},{"key":"18338_CR4","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s10571-011-9754-6","volume":"32","author":"JM Saavedra","year":"2012","unstructured":"Saavedra, J. M. Angiotensin II AT(1) receptor blockers ameliorate inflammatory stress: A beneficial effect for the treatment of brain disorders. Cell. Mol. Neurobiol. 32, 667\u2013681. https:\/\/doi.org\/10.1007\/s10571-011-9754-6 (2012).","journal-title":"Cell. Mol. Neurobiol."},{"key":"18338_CR5","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1097\/CCM.0b013e31822f08b9","volume":"40","author":"R Timaru-Kast","year":"2012","unstructured":"Timaru-Kast, R. et al. Delayed inhibition of angiotensin II receptor type 1 reduces secondary brain damage and improves functional recovery after experimental brain trauma*. Crit. Care Med. 40, 935\u2013944. https:\/\/doi.org\/10.1097\/CCM.0b013e31822f08b9 (2012).","journal-title":"Crit. Care Med."},{"key":"18338_CR6","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awv172","author":"S Villapol","year":"2015","unstructured":"Villapol, S., Balarezo, M. G., Affram, K., Saavedra, J. M. & Symes, A. J. Neurorestoration after traumatic brain injury through angiotensin II receptor blockage. Brain J. Neurol. https:\/\/doi.org\/10.1093\/brain\/awv172 (2015).","journal-title":"Brain J. Neurol."},{"key":"18338_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3389\/fnagi.2019.00063","volume":"11","author":"R Timaru-Kast","year":"2019","unstructured":"Timaru-Kast, R. et al. Angiotensin II receptor 1 blockage limits brain damage and improves functional outcome after brain injury in aged animals despite age-dependent reduction in AT1 expression. Front. Aging Neurosci. 11, 18. https:\/\/doi.org\/10.3389\/fnagi.2019.00063 (2019).","journal-title":"Front. Aging Neurosci."},{"key":"18338_CR8","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.tips.2010.09.005","volume":"31","author":"DJ Loane","year":"2010","unstructured":"Loane, D. J. & Faden, A. I. Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies. Trends Pharmacol. Sci. 31, 596\u2013604. https:\/\/doi.org\/10.1016\/j.tips.2010.09.005 (2010).","journal-title":"Trends Pharmacol. Sci."},{"key":"18338_CR9","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/1440-1681.12137","volume":"40","author":"C Sumners","year":"2013","unstructured":"Sumners, C. et al. Protective arms of the renin-angiotensin-system in neurological disease. Clin. Exp. Pharmacol. Physiol. 40, 580\u2013588. https:\/\/doi.org\/10.1111\/1440-1681.12137 (2013).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"18338_CR10","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.nbd.2012.11.008","volume":"51","author":"P Namsolleck","year":"2013","unstructured":"Namsolleck, P. et al. AT2-receptor stimulation enhances axonal plasticity after spinal cord injury by upregulating BDNF expression. Neurobiol. Dis. 51, 177\u2013191. https:\/\/doi.org\/10.1016\/j.nbd.2012.11.008 (2013).","journal-title":"Neurobiol. Dis."},{"key":"18338_CR11","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1006\/frne.1993.1005","volume":"14","author":"SP Bottari","year":"1993","unstructured":"Bottari, S. P., de Gasparo, M., Steckelings, U. M. & Levens, N. R. Angiotensin II receptor subtypes: Characterization, signalling mechanisms, and possible physiological implications. Front. Neuroendocrinol. 14, 123\u2013171. https:\/\/doi.org\/10.1006\/frne.1993.1005 (1993).","journal-title":"Front. Neuroendocrinol."},{"key":"18338_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1161\/01.ATV.0000150662.51436.14","volume":"25","author":"CJ Wruck","year":"2005","unstructured":"Wruck, C. J. et al. Regulation of transport of the angiotensin AT2 receptor by a novel membrane-associated Golgi protein. Arterioscler. Thromb. Vasc. Biol. 25, 57\u201364. https:\/\/doi.org\/10.1161\/01.ATV.0000150662.51436.14 (2005).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"18338_CR13","doi-asserted-by":"crossref","unstructured":"Laflamme, L., Gasparo, M., Gallo, J. M., Payet, M. D. & Gallo-Payet, N. Angiotensin II induction of neurite outgrowth by AT2 receptors in NG108\u201315 cells. Effect counteracted by the AT1 receptors.J. boil. chem. 271, 22729\u201322735 (1996).","DOI":"10.1074\/jbc.271.37.22729"},{"key":"18338_CR14","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1677\/jme.0.0310359","volume":"31","author":"L Gendron","year":"2003","unstructured":"Gendron, L., Payet, M. D. & Gallo-Payet, N. The angiotensin type 2 receptor of angiotensin II and neuronal differentiation: From observations to mechanisms. J. Mol. Endocrinol. 31, 359\u2013372 (2003).","journal-title":"J. Mol. Endocrinol."},{"key":"18338_CR15","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1096\/fj.02-1193fje","volume":"17","author":"K Reinecke","year":"2003","unstructured":"Reinecke, K. et al. Angiotensin II accelerates functional recovery in the rat sciatic nerve in vivo: Role of the AT2 receptor and the transcription factor NF-kappaB. FASEB J. Off. Publ. Federation Am. Soc. Exp. Biol. 17, 2094\u20132096. https:\/\/doi.org\/10.1096\/fj.02-1193fje (2003).","journal-title":"FASEB J. Off. Publ. Federation Am. Soc. Exp. Biol."},{"key":"18338_CR16","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.1074\/jbc.M202446200","volume":"278","author":"L Gendron","year":"2003","unstructured":"Gendron, L., Oligny, J. F., Payet, M. D. & Gallo-Payet, N. Cyclic AMP-independent involvement of Rap1\/B-Raf in the angiotensin II AT2 receptor signaling pathway in NG108-15 cells. J. Biol. Chem. 278, 3606\u20133614. https:\/\/doi.org\/10.1074\/jbc.M202446200 (2003).","journal-title":"J. Biol. Chem."},{"key":"18338_CR17","first-page":"617","volume":"19","author":"J Li","year":"2005","unstructured":"Li, J. et al. Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury. FASEB J. 19, 617\u2013619 (2005).","journal-title":"FASEB J."},{"key":"18338_CR18","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1161\/01.HYP.33.2.613","volume":"33","author":"M Horiuchi","year":"1999","unstructured":"Horiuchi, M., Akishita, M. & Dzau, V. J. Recent progress in angiotensin II type 2 receptor research in the cardiovascular system. Hypertension 33, 613\u2013621 (1999).","journal-title":"Hypertension"},{"key":"18338_CR19","first-page":"1099","volume":"26","author":"JM Saavedra","year":"2006","unstructured":"Saavedra, J. M., Benicky, J. & Zhou, J. Mechanisms of the anti-ischemic effect of angiotensin II AT(1) receptor antagonists in the brain. Cell Mol. Neurobiol. 26, 1099\u20131111 (2006).","journal-title":"Cell Mol. Neurobiol."},{"key":"18338_CR20","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1161\/01.CIR.0000138848.58269.80","volume":"110","author":"M Iwai","year":"2004","unstructured":"Iwai, M. et al. Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation. Circulation 110, 843\u2013848 (2004).","journal-title":"Circulation"},{"key":"18338_CR21","doi-asserted-by":"publisher","first-page":"958","DOI":"10.2741\/3289","volume":"14","author":"ER Porrello","year":"2009","unstructured":"Porrello, E. R., Delbridge, L. M. & Thomas, W. G. The angiotensin II type 2 (AT2) receptor: An enigmatic seven transmembrane receptor. Front Biosci. (Landmark Ed) 14, 958\u2013972 (2009).","journal-title":"Front Biosci. (Landmark Ed)"},{"key":"18338_CR22","doi-asserted-by":"publisher","first-page":"4646","DOI":"10.1210\/en.2005-1315","volume":"147","author":"B Plouffe","year":"2006","unstructured":"Plouffe, B., Guimond, M. O., Beaudry, H. & Gallo-Payet, N. Role of tyrosine kinase receptors in angiotensin II AT2 receptor signaling: Involvement in neurite outgrowth and in p42\/p44mapk activation in NG108-15 cells. Endocrinology 147, 4646\u20134654. https:\/\/doi.org\/10.1210\/en.2005-1315 (2006).","journal-title":"Endocrinology"},{"key":"18338_CR23","doi-asserted-by":"publisher","first-page":"925","DOI":"10.2337\/db11-1468","volume":"61","author":"N Hashikawa-Hobara","year":"2012","unstructured":"Hashikawa-Hobara, N. et al. Candesartan cilexetil improves angiotensin II type 2 receptor-mediated neurite outgrowth via the PI3K-Akt pathway in fructose-induced insulin-resistant rats. Diabetes 61, 925\u2013932. https:\/\/doi.org\/10.2337\/db11-1468 (2012).","journal-title":"Diabetes"},{"key":"18338_CR24","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s13311-014-0286-x","volume":"11","author":"G Umschweif","year":"2014","unstructured":"Umschweif, G. et al. Angiotensin receptor type 2 activation induces neuroprotection and neurogenesis after traumatic brain injury. Neurotherapeutics J. Am. Soc. Exp. NeuroTherapeutics 11, 665\u2013678. https:\/\/doi.org\/10.1007\/s13311-014-0286-x (2014).","journal-title":"Neurotherapeutics J. Am. Soc. Exp. NeuroTherapeutics"},{"key":"18338_CR25","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s00109-016-1406-3","volume":"94","author":"K Schwengel","year":"2016","unstructured":"Schwengel, K. et al. Angiotensin AT2-receptor stimulation improves survival and neurological outcome after experimental stroke in mice. J. Mol. Med. (Berl.) 94, 957\u2013966. https:\/\/doi.org\/10.1007\/s00109-016-1406-3 (2016).","journal-title":"J. Mol. Med. (Berl.)"},{"key":"18338_CR26","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1042\/CS20171549","volume":"132","author":"DM Bennion","year":"2018","unstructured":"Bennion, D. M., Steckelings, U. M. & Sumners, C. Neuroprotection via AT2 receptor agonists in ischemic stroke. Clin. Sci. (Lond.) 132, 1055\u20131067. https:\/\/doi.org\/10.1042\/CS20171549 (2018).","journal-title":"Clin. Sci. (Lond.)"},{"key":"18338_CR27","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/ana.25458","volume":"85","author":"EV Griemert","year":"2019","unstructured":"Griemert, E. V. et al. Plasminogen activator inhibitor-1 augments damage by impairing fibrinolysis after traumatic brain injury. Ann. Neurol. 85, 667\u2013680. https:\/\/doi.org\/10.1002\/ana.25458 (2019).","journal-title":"Ann. Neurol."},{"key":"18338_CR28","doi-asserted-by":"crossref","unstructured":"Thal, S. C. & Plesnila, N. Non-invasive intraoperative monitoring of blood pressure and arterial pCO(2) during surgical anesthesia in mice. J.Neurosci.Methods 159, 261\u2013267 (2007).","DOI":"10.1016\/j.jneumeth.2006.07.016"},{"key":"18338_CR29","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1089\/neu.2007.0452","volume":"25","author":"J Tsenter","year":"2008","unstructured":"Tsenter, J. et al. Dynamic changes in the recovery after traumatic brain injury in mice: Effect of injury severity on T2-weighted MRI abnormalities, and motor and cognitive functions. J. Neurotrauma 25, 324\u2013333 (2008).","journal-title":"J. Neurotrauma"},{"key":"18338_CR30","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1097\/CCM.0b013e31827ca494","volume":"41","author":"SC Thal","year":"2013","unstructured":"Thal, S. C. et al. Inhibition of proteasomal glucocorticoid receptor degradation restores dexamethasone-mediated stabilization of the blood-brain barrier after traumatic brain injury. Crit. Care Med. 41, 1305\u20131315. https:\/\/doi.org\/10.1097\/CCM.0b013e31827ca494 (2013).","journal-title":"Crit. Care Med."},{"key":"18338_CR31","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3389\/fnagi.2017.00208","volume":"9","author":"CK Donat","year":"2017","unstructured":"Donat, C. K., Scott, G., Gentleman, S. M. & Sastre, M. Microglial activation in traumatic brain injury. Front Aging Neurosci. 9, 208. https:\/\/doi.org\/10.3389\/fnagi.2017.00208 (2017).","journal-title":"Front Aging Neurosci."},{"key":"18338_CR32","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1111\/j.1471-4159.2009.06514.x","volume":"112","author":"C Luh","year":"2010","unstructured":"Luh, C. et al. Inhibition of myosin light chain kinase reduces brain edema formation after traumatic brain injury. J. Neurochem. 112, 1015\u20131025. https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06514.x (2010).","journal-title":"J. Neurochem."},{"key":"18338_CR33","doi-asserted-by":"publisher","first-page":"e43829","DOI":"10.1371\/journal.pone.0043829","volume":"7","author":"R Timaru-Kast","year":"2012","unstructured":"Timaru-Kast, R. et al. Influence of age on brain edema formation, secondary brain damage and inflammatory response after brain trauma in mice. PLoS ONE 7, e43829. https:\/\/doi.org\/10.1371\/journal.pone.0043829 (2012).","journal-title":"PLoS ONE"},{"key":"18338_CR34","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2014.3784","author":"R Timaru-Kast","year":"2015","unstructured":"Timaru-Kast, R., Herbig, E. L., Luh, C., Engelhard, K. & Thal, S. C. Influence of age on cerebral housekeeping gene expression for normalization of quantitative PCR after acute brain injury in mice. J. Neurotrauma https:\/\/doi.org\/10.1089\/neu.2014.3784 (2015).","journal-title":"J. Neurotrauma"},{"key":"18338_CR35","doi-asserted-by":"publisher","unstructured":"Faul, F., Erdfelder, E., Buchner, A. & Lang, A. G. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav. Res. Methods 41, 1149-1160, doi:https:\/\/doi.org\/10.3758\/BRM.41.4.1149 (2009)","DOI":"10.3758\/BRM.41.4.1149"},{"key":"18338_CR36","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fnagi.2019.00063","volume":"11","author":"R Timaru-Kast","year":"2019","unstructured":"Timaru-Kast, R. et al. Angiotensin II receptor 1 blockage limits brain damage and improves functional outcome after brain injury in aged animals despite age-dependent reduction in AT1 expression. Front Aging Neurosci. 11, 63. https:\/\/doi.org\/10.3389\/fnagi.2019.00063 (2019).","journal-title":"Front Aging Neurosci."},{"key":"18338_CR37","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1038\/npp.2012.152","volume":"37","author":"S Villapol","year":"2012","unstructured":"Villapol, S. et al. Candesartan, an angiotensin II AT(1)-receptor blocker and PPAR-gamma agonist, reduces lesion volume and improves motor and memory function after traumatic brain injury in mice. Neuropsychopharmacol. Off. Publ. Am. College Neuropsychopharmacol. 37, 2817\u20132829. https:\/\/doi.org\/10.1038\/npp.2012.152 (2012).","journal-title":"Neuropsychopharmacol. Off. Publ. Am. College Neuropsychopharmacol."},{"key":"18338_CR38","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1161\/HYPERTENSIONAHA.112.199646","volume":"60","author":"CA McCarthy","year":"2012","unstructured":"McCarthy, C. A. et al. Angiotensin II type 2 receptor stimulation initiated after stroke causes neuroprotection in conscious rats. Hypertension 60, 1531\u20131537. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.112.199646 (2012).","journal-title":"Hypertension"},{"key":"18338_CR39","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/bja\/aem131","volume":"99","author":"C Werner","year":"2007","unstructured":"Werner, C. & Engelhard, K. Pathophysiology of traumatic brain injury. Br. J. Anaesth. 99, 4\u20139. https:\/\/doi.org\/10.1093\/bja\/aem131 (2007).","journal-title":"Br. J. Anaesth."},{"key":"18338_CR40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-1-4939-3816-2_3","volume":"1462","author":"N Marklund","year":"2016","unstructured":"Marklund, N. Rodent models of traumatic brain injury: Methods and challenges. Methods Mol. Biol. 1462, 29\u201346. https:\/\/doi.org\/10.1007\/978-1-4939-3816-2_3 (2016).","journal-title":"Methods Mol. Biol."},{"key":"18338_CR41","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1602\/neurorx.2.3.410","volume":"2","author":"I Cernak","year":"2005","unstructured":"Cernak, I. Animal models of head trauma. NeuroRx 2, 410\u2013422. https:\/\/doi.org\/10.1602\/neurorx.2.3.410 (2005).","journal-title":"NeuroRx"},{"key":"18338_CR42","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1038\/jcbfm.2014.93","volume":"34","author":"G Umschweif","year":"2014","unstructured":"Umschweif, G. et al. Neuroprotection after traumatic brain injury in heat-acclimated mice involves induced neurogenesis and activation of angiotensin receptor type 2 signaling. J. Cereb. Blood flow Metabolism Off. J. Int. Soc. Cereb. Blood Flow Metabolism 34, 1381\u20131390. https:\/\/doi.org\/10.1038\/jcbfm.2014.93 (2014).","journal-title":"J. Cereb. Blood flow Metabolism Off. J. Int. Soc. Cereb. Blood Flow Metabolism"},{"key":"18338_CR43","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1038\/nprot.2009.148","volume":"4","author":"MA Flierl","year":"2009","unstructured":"Flierl, M. A. et al. Mouse closed head injury model induced by a weight-drop device. Nat. Protoc. 4, 1328\u20131337. https:\/\/doi.org\/10.1038\/nprot.2009.148 (2009).","journal-title":"Nat. Protoc."},{"key":"18338_CR44","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1089\/neu.1996.13.557","volume":"13","author":"Y Chen","year":"1996","unstructured":"Chen, Y., Constantini, S., Trembovler, V., Weinstock, M. & Shohami, E. An experimental model of closed head injury in mice: Pathophysiology, histopathology, and cognitive deficits. J. Neurotrauma 13, 557\u2013568. https:\/\/doi.org\/10.1089\/neu.1996.13.557 (1996).","journal-title":"J. Neurotrauma"},{"key":"18338_CR45","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/978-1-4939-3816-2_2","volume":"1462","author":"J Berkner","year":"2016","unstructured":"Berkner, J., Mannix, R. & Qiu, J. Clinical traumatic brain injury in the preclinical setting. Methods Mol. Biol. 1462, 11\u201328. https:\/\/doi.org\/10.1007\/978-1-4939-3816-2_2 (2016).","journal-title":"Methods Mol. Biol."},{"key":"18338_CR46","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.4161\/cc.4.9.1996","volume":"4","author":"I Cernak","year":"2005","unstructured":"Cernak, I., Stoica, B., Byrnes, K. R., Di, G. S. & Faden, A. I. Role of the cell cycle in the pathobiology of central nervous system trauma. Cell Cycle 4, 1286\u20131293 (2005).","journal-title":"Cell Cycle"},{"key":"18338_CR47","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1089\/neu.1995.12.169","volume":"12","author":"DH Smith","year":"1995","unstructured":"Smith, D. H. et al. A model of parasagittal controlled cortical impact in the mouse: Cognitive and histopathologic effects. J. Neurotrauma 12, 169\u2013178. https:\/\/doi.org\/10.1089\/neu.1995.12.169 (1995).","journal-title":"J. Neurotrauma"},{"key":"18338_CR48","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/01.WCB.0000046144.31247.33","volume":"23","author":"AI Faden","year":"2003","unstructured":"Faden, A. I. et al. Neuroprotective and nootropic actions of a novel cyclized dipeptide after controlled cortical impact injury in mice. J. Cereb. Blood flow Metabolism Off. J. Int. Soc. Cereb. Blood Flow Metabolism 23, 355\u2013363. https:\/\/doi.org\/10.1097\/01.WCB.0000046144.31247.33 (2003).","journal-title":"J. Cereb. Blood flow Metabolism Off. J. Int. Soc. Cereb. Blood Flow Metabolism"},{"key":"18338_CR49","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/01.WCB.0000044631.80210.3C","volume":"23","author":"Y Chen","year":"2003","unstructured":"Chen, Y. & Swanson, R. A. Astrocytes and brain injury. J. Cereb. Blood flow Metabolism Off. J. Int. Soc. Cereb. Blood Flow Metabolism 23, 137\u2013149. https:\/\/doi.org\/10.1097\/01.WCB.0000044631.80210.3C (2003).","journal-title":"J. Cereb. Blood flow Metabolism Off. J. Int. Soc. Cereb. Blood Flow Metabolism"},{"key":"18338_CR50","doi-asserted-by":"publisher","first-page":"8182","DOI":"10.1523\/JNEUROSCI.19-19-08182.1999","volume":"19","author":"MT Fitch","year":"1999","unstructured":"Fitch, M. T., Doller, C., Combs, C. K., Landreth, G. E. & Silver, J. Cellular and molecular mechanisms of glial scarring and progressive cavitation: In vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma. J. Neurosci. Off. J. Soc. Neurosci. 19, 8182\u20138198 (1999).","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"18338_CR51","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12974-019-1550-0","volume":"16","author":"TJ Kramer","year":"2019","unstructured":"Kramer, T. J. et al. Depletion of regulatory T cells increases T cell brain infiltration, reactive astrogliosis, and interferon-gamma gene expression in acute experimental traumatic brain injury. J. Neuroinflammation 16, 163. https:\/\/doi.org\/10.1186\/s12974-019-1550-0 (2019).","journal-title":"J. Neuroinflammation"},{"key":"18338_CR52","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12974-019-1577-2","volume":"16","author":"TJ Kramer","year":"2019","unstructured":"Kramer, T. J. et al. Correction to: Depletion of regulatory T cells increases T cell brain infiltration, reactive astrogliosis, and interferon-gamma gene expression in acute experimental traumatic brain injury. J. Neuroinflammation 16, 176. https:\/\/doi.org\/10.1186\/s12974-019-1577-2 (2019).","journal-title":"J. Neuroinflammation"},{"key":"18338_CR53","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/glia.23091","volume":"65","author":"L Menzel","year":"2017","unstructured":"Menzel, L. et al. Progranulin protects against exaggerated axonal injury and astrogliosis following traumatic brain injury. Glia 65, 278\u2013292. https:\/\/doi.org\/10.1002\/glia.23091 (2017).","journal-title":"Glia"},{"key":"18338_CR54","doi-asserted-by":"publisher","unstructured":"Steckelings, U. M. et al. The past, present and future of angiotensin II type 2 receptor stimulation. J. Renin-Angiotensin-Aldosterone Syst. JRAAS 11, 67\u201373, https:\/\/doi.org\/10.1177\/1470320309347791 (2010).","DOI":"10.1177\/1470320309347791"},{"key":"18338_CR55","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.coph.2010.11.002","volume":"11","author":"UM Steckelings","year":"2011","unstructured":"Steckelings, U. M. et al. Non-peptide AT2-receptor agonists. Curr. Opin. Pharmacol. 11, 187\u2013192. https:\/\/doi.org\/10.1016\/j.coph.2010.11.002 (2011).","journal-title":"Curr. Opin. Pharmacol."},{"key":"18338_CR56","doi-asserted-by":"publisher","first-page":"5995","DOI":"10.1021\/jm049715t","volume":"47","author":"Y Wan","year":"2004","unstructured":"Wan, Y. et al. Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist. J. Med. Chem. 47, 5995\u20136008. https:\/\/doi.org\/10.1021\/jm049715t (2004).","journal-title":"J. Med. Chem."},{"key":"18338_CR57","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s11906-013-0416-6","volume":"16","author":"P Namsolleck","year":"2014","unstructured":"Namsolleck, P., Recarti, C., Foulquier, S., Steckelings, U. M. & Unger, T. AT(2) receptor and tissue injury: Therapeutic implications. Curr. Hypertens. Rep. 16, 416. https:\/\/doi.org\/10.1007\/s11906-013-0416-6 (2014).","journal-title":"Curr. Hypertens. Rep."},{"key":"18338_CR58","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1161\/CIRCULATIONAHA.108.784868","volume":"118","author":"E Kaschina","year":"2008","unstructured":"Kaschina, E. et al. Angiotensin II type 2 receptor stimulation: A novel option of therapeutic interference with the renin-angiotensin system in myocardial infarction?. Circulation 118, 2523\u20132532. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.784868 (2008).","journal-title":"Circulation"},{"key":"18338_CR59","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/HJH.0000000000000364","volume":"33","author":"A Alhusban","year":"2015","unstructured":"Alhusban, A. et al. Compound 21 is pro-angiogenic in the brain and results in sustained recovery after ischemic stroke. J. Hypertens. 33, 170\u2013180. https:\/\/doi.org\/10.1097\/HJH.0000000000000364 (2015).","journal-title":"J. Hypertens."},{"key":"18338_CR60","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jneumeth.2011.06.009","volume":"202","author":"N Shraim","year":"2011","unstructured":"Shraim, N. et al. Microbore liquid chromatography with UV detection to study the in vivo passage of compound 21, a non-peptidergic AT(2) receptor agonist, to the striatum in rats. J. Neurosci. Meth. 202, 137\u2013142. https:\/\/doi.org\/10.1016\/j.jneumeth.2011.06.009 (2011).","journal-title":"J. Neurosci. Meth."},{"key":"18338_CR61","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1042\/CS20180100","volume":"132","author":"DM Bennion","year":"2018","unstructured":"Bennion, D. M. et al. Protective effects of the angiotensin II AT2 receptor agonist compound 21 in ischemic stroke: A nose-to-brain delivery approach. Clin. Sci. (Lond.) 132, 581\u2013593. https:\/\/doi.org\/10.1042\/CS20180100 (2018).","journal-title":"Clin. Sci. (Lond.)"},{"key":"18338_CR62","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1159\/000368597","volume":"38","author":"A Moisan","year":"2014","unstructured":"Moisan, A. et al. Microvascular plasticity after experimental stroke: A molecular and MRI study. Cerebrovasc Dis 38, 344\u2013353. https:\/\/doi.org\/10.1159\/000368597 (2014).","journal-title":"Cerebrovasc Dis"},{"key":"18338_CR63","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/s0304-3940(97)00239-5","volume":"226","author":"MK Baskaya","year":"1997","unstructured":"Baskaya, M. K., Rao, A. M., Dogan, A., Donaldson, D. & Dempsey, R. J. The biphasic opening of the blood-brain barrier in the cortex and hippocampus after traumatic brain injury in rats. Neurosci. Lett. 226, 33\u201336. https:\/\/doi.org\/10.1016\/s0304-3940(97)00239-5 (1997).","journal-title":"Neurosci. Lett."},{"key":"18338_CR64","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/0031-9384(95)02211-2","volume":"60","author":"BA Baldwin","year":"1996","unstructured":"Baldwin, B. A. & Sukhchai, S. Intracerebroventricular injection of CCK reduces operant sugar intake in pigs. Physiol. Behav. 60, 231\u2013233. https:\/\/doi.org\/10.1016\/0031-9384(95)02211-2 (1996).","journal-title":"Physiol. Behav."},{"key":"18338_CR65","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1136\/jnnp.2007.126425","volume":"79","author":"O Tomkins","year":"2008","unstructured":"Tomkins, O. et al. Blood-brain barrier disruption in post-traumatic epilepsy. J. Neurol. Neurosurg. Psychiatry 79, 774\u2013777. https:\/\/doi.org\/10.1136\/jnnp.2007.126425 (2008).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"18338_CR66","doi-asserted-by":"publisher","DOI":"10.1007\/s12017-021-08687-7","author":"S Ismael","year":"2021","unstructured":"Ismael, S. & Ishrat, T. Compound 21, a direct AT2R agonist, induces IL-10 and inhibits inflammation in mice following traumatic brain injury. Neuromolecular Med. https:\/\/doi.org\/10.1007\/s12017-021-08687-7 (2021).","journal-title":"Neuromolecular Med."},{"key":"18338_CR67","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/2040-7378-4-16","volume":"4","author":"S Lee","year":"2012","unstructured":"Lee, S. et al. Neuroprotective effect of an angiotensin receptor type 2 agonist following cerebral ischemia in vitro and in vivo. Exp. Transl. Stroke Med. 4, 16. https:\/\/doi.org\/10.1186\/2040-7378-4-16 (2012).","journal-title":"Exp. Transl. Stroke Med."},{"key":"18338_CR68","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1042\/CS20110036","volume":"121","author":"S Bosnyak","year":"2011","unstructured":"Bosnyak, S. et al. Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors. Clin. Sci. (Lond.) 121, 297\u2013303. https:\/\/doi.org\/10.1042\/CS20110036 (2011).","journal-title":"Clin. Sci. (Lond.)"},{"key":"18338_CR69","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/j.1476-5381.2009.00575.x","volume":"159","author":"S Bosnyak","year":"2010","unstructured":"Bosnyak, S. et al. Stimulation of angiotensin AT2 receptors by the non-peptide agonist, compound 21, evokes vasodepressor effects in conscious spontaneously hypertensive rats. Br. J. Pharmacol. 159, 709\u2013716. https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00575.x (2010).","journal-title":"Br. J. Pharmacol."},{"key":"18338_CR70","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/1440-1681.12067","volume":"40","author":"LM Hilliard","year":"2013","unstructured":"Hilliard, L. M., Mirabito, K. M. & Denton, K. M. Unmasking the potential of the angiotensin AT2 receptor as a therapeutic target in hypertension in men and women: What we know and what we still need to find out. Clin. Exp. Pharmacol. Physiol. 40, 542\u2013550. https:\/\/doi.org\/10.1111\/1440-1681.12067 (2013).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"18338_CR71","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1161\/01.RES.86.12.1266","volume":"86","author":"M Ruiz-Ortega","year":"2000","unstructured":"Ruiz-Ortega, M. et al. Angiotensin II activates nuclear transcription factor kappaB through AT(1) and AT(2) in vascular smooth muscle cells: Molecular mechanisms. Circ. Res. 86, 1266\u20131272 (2000).","journal-title":"Circ. Res."},{"issue":"Suppl 1","key":"18338_CR72","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/ndt\/16.suppl_1.27","volume":"16","author":"M Ruiz-Ortega","year":"2001","unstructured":"Ruiz-Ortega, M., Lorenzo, O., Ruperez, M., Suzuki, Y. & Egido, J. Angiotensin II activates nuclear transcription factor-kappaB in aorta of normal rats and in vascular smooth muscle cells of AT1 knockout mice. Nephrol. Dial. Transplant. 16(Suppl 1), 27\u201333 (2001).","journal-title":"Nephrol. Dial. Transplant."},{"key":"18338_CR73","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S1357-2725(02)00271-6","volume":"35","author":"Y Suzuki","year":"2003","unstructured":"Suzuki, Y. et al. Inflammation and angiotensin II. Int. J. Biochem. Cell Biol. 35, 881\u2013900 (2003).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"18338_CR74","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1016\/S0002-9440(10)64130-2","volume":"158","author":"M Ruiz-Ortega","year":"2001","unstructured":"Ruiz-Ortega, M., Lorenzo, O., Ruperez, M., Blanco, J. & Egido, J. Systemic infusion of angiotensin II into normal rats activates nuclear factor-kappaB and AP-1 in the kidney: Role of AT(1) and AT(2) receptors. Am. J. Pathol. 158, 1743\u20131756 (2001).","journal-title":"Am. J. Pathol."},{"key":"18338_CR75","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/ndt\/17.2.195","volume":"17","author":"G Wolf","year":"2002","unstructured":"Wolf, G. \u201cThe road not taken\u201d: Role of angiotensin II type 2 receptor in pathophysiology. Nephrol. Dial. Transplant. 17, 195\u2013198 (2002).","journal-title":"Nephrol. Dial. Transplant."},{"key":"18338_CR76","doi-asserted-by":"publisher","first-page":"F700","DOI":"10.1152\/ajprenal.00616.2010","volume":"300","author":"R Sabuhi","year":"2011","unstructured":"Sabuhi, R., Ali, Q., Asghar, M., Al-Zamily, N. R. & Hussain, T. Role of the angiotensin II AT2 receptor in inflammation and oxidative stress: Opposing effects in lean and obese Zucker rats. Am. J. Physiol. Renal Physiol. 300, F700-706. https:\/\/doi.org\/10.1152\/ajprenal.00616.2010 (2011).","journal-title":"Am. J. Physiol. Renal Physiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18338-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18338-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18338-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T07:25:42Z","timestamp":1669361142000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18338-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,22]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["18338"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-18338-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,22]]},"assertion":[{"value":"12 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14280"}}